Homoarginine and Progression of Chronic Kidney Disease: Results from the Mild to Moderate Kidney Disease Study

• Christiane Drechsler,

  Affiliation Division of Nephrology, Department of Medicine, University of Würzburg, Würzburg, Germany

  ⨯
• Barbara Kollerits,

  Affiliation Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Innsbruck Medical University, Innsbruck, Austria

  ⨯
• Andreas Meinitzer,

  Affiliation Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria

  ⨯
• Winfried März,

  Affiliation Department of Public Health, Social and Preventive Medicine, Mannheim Medical Faculty, University of Heidelberg, Mannheim, Germany

  ⨯
• Eberhard Ritz,

  Affiliation Department of Internal Medicine, Division of Nephrology, Ruprecht-Karls-University, Heidelberg, Germany

  ⨯
• Paul König,

  Affiliation Innsbruck University Hospital, Department of Clinical Nephrology, Innsbruck, Austria

  ⨯
• Ulrich Neyer,

  Affiliation Department of Nephrology and Dialysis, Academic Teaching Hospital, Feldkirch, Austria

  ⨯
• Stefan Pilz,

  Affiliations Department of Epidemiology and Biostatistics, EMGO Institute for Health and Care Research, VU University Medical Centre, Amsterdam, The Netherlands, Department of Internal Medicine, Division of Endocrinology and Metabolism, Medical University of Graz, Graz, Austria

  ⨯
• Christoph Wanner,

  Affiliation Division of Nephrology, Department of Medicine, University of Würzburg, Würzburg, Germany

  ⨯
• Florian Kronenberg ,

  * E-mail: Florian.Kronenberg@i-med.ac.at

  Affiliation Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Innsbruck Medical University, Innsbruck, Austria

  ⨯
• for the MMKD Study Group

  ¶Membership of the MMKD Study Group is provided in the Acknowledgments

  ⨯